ArticleProceedings of the National Academy of Sciences of the United States of America2021
Anatomy of an extensively drug-resistant
Open access · hybridAbstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.6field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 69 citations in OpenAlex.
- Emergence ofVirulence · 2026Article
- Emergence and Dissemination of NDM+OXA-48-like Co-ProducingAntibiotics (Basel, Switzerland) · 2026Article
- Antimicrobial resistance and plasmidome of carbapenemase-resistant Klebsiella pneumoniae causing bloodstream infections between 2014 and 2024.BMC microbiology · 2026Article
- Enhanced invasiveness promotes the dominance of a widely-distributed carbapenem-resistant virulence-plasmid-carrying Klebsiella pneumoniae sublineage.Nature communications · 2026Article
- Life Identification Numbers: A strain nomenclature approach to aid epidemiological surveillance of bacterial pathogens.PLoS biology · 2026Article
- Article
- Genomic Epidemiology of ClinicalAntibiotics (Basel, Switzerland) · 2026Article
- Preferred evolutionary routes of convergence in Klebsiella pneumoniae favor siderophore acquisition over hypervirulence.Research square · 2026Article
- Suspected community-acquisition of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CRhvKp) in Germany: a case report and implications for infection control.GMS hygiene and infection control · 2026Article
- Hybrid plasmids: genetic diversity and hypervirulent phenotype ofFrontiers in microbiology · 2026Article
- Co-Occurrence of Resistance to Aminoglycosides and Carbapenems inInternational journal of microbiology · 2026Review
- Systematic review on genomic insights into antimicrobial resistance in ESKAPE pathogens.African journal of laboratory medicine · 2026Review
- Article
- Parallel within-host evolution alters virulence factors in an opportunistic Klebsiella pneumoniae during a hospital outbreak.Nature communications · 2025Article
- How Klebsiella pneumoniae controls its virulence.PLoS pathogens · 2025Review
- Genomic characterization and comparative analysis of antibiotic resistance and virulence in Bangladeshi and global Klebsiella pneumoniae ST48 strains.Journal, genetic engineering & biotechnology · 2025Article
- Phage Host Range Expansion Through Directed Evolution on Highly Phage-Resistant Strains ofInternational journal of molecular sciences · 2025Article
- Article
- The pivotal role of IncFIB(Mar) plasmid in the emergence and spread of hypervirulent carbapenem-resistantScience advances · 2025Article
- The Synergy of Machine Learning and Epidemiology in Addressing Carbapenem Resistance: A Comprehensive Review.Antibiotics (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 7 institutions in 4 countries.
Melissa J MartinMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Brendan W CoreyMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.ORCID 0000-0003-2289-8723
Filomena SannioDipartimento di Biotecnologie Mediche, University of Siena I-53100 Siena, Italy.
Lindsey R HallMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.ORCID 0000-0002-6012-9899
Ulrike MacDonaldVeterans Administration Western New York Healthcare System, University at Buffalo, State University of New York, Buffalo, NY 14215.ORCID 0000-0002-3460-7789
Brendan T JonesMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Emma G MillsMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Casey HarlessMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Jason StamMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Rosslyn MaybankMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Yoon KwakMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Katharina SchauflerInstitute of Pharmacy, Pharmaceutical Microbiology, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-2669-8799
Karsten BeckerFriedrich Loeffler Institute of Medical Microbiology, University of Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-6391-1341
Nils-Olaf HübnerCentral Unit for Infection Prevention and Control, University Medicine Greifswald, 17475 Greifswald, Germany.
Stefania CrestiDipartimento di Biotecnologie Mediche, University of Siena I-53100 Siena, Italy.
Giacinta TordiniDipartimento di Biotecnologie Mediche, University of Siena I-53100 Siena, Italy.
Marcello ValassinaUnita Operativa Complessa di Microbiologia e Virologia, Azienda Ospedaliera Universitaria Senese, I-53100 Siena, Italy.
Maria Grazia CusiDipartimento di Biotecnologie Mediche, University of Siena I-53100 Siena, Italy.ORCID 0000-0001-8869-8164
Jason W BennettMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
Thomas A RussoVeterans Administration Western New York Healthcare System, University at Buffalo, State University of New York, Buffalo, NY 14215.ORCID 0000-0003-4566-7442
Patrick T McGannMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910.ORCID 0000-0003-1548-9438
Francois LebretonMultidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD 20910; francois.lebreton.ctr@mail.mil jddocquier@unisi.it.ORCID 0000-0002-7157-5026
Jean-Denis DocquierDipartimento di Biotecnologie Mediche, University of Siena I-53100 Siena, Italy; francois.lebreton.ctr@mail.mil jddocquier@unisi.it.ORCID 0000-0001-9483-4476
Walter Reed Army Institute of Research · USUniversity of Siena · ITVA Western New York Healthcare System · USAzienda Ospedaliera Universitaria Senese · ITChristian-Albrechts-Universität zu Kiel · DEFriedrich-Loeffler-Institut · DEUniversitätsmedizin Greifswald · DE
Funding
Development of a diagnostic test for hypervirulent Klebsiella pneumoniaeR21AI123558 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUSSO, THOMAS A · 2016 to 2017
$439kIdentification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae.R21AI141826 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUSSO, THOMAS A · 2020 to 2021
$432kDetermining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannniiI01BX004677 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI THOMAS A RUSSO · 2020 to 2026
–BLRD VA I01 BX004677NIAID NIH HHS R21 AI123558NIAID NIH HHS R21 AI141826
Abstract
A protracted outbreak of New Delhi metallo-β-lactamase (NDM)-producing carbapenem-resistant
Indexed as
Disease OutbreaksAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBiomarkersCarbapenemsColistinComputational BiologyCross InfectionDrug Resistance, Multiple, BacterialHumansItalyKaplan-Meier EstimateKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesBiomarkersCarbapenemsColistinPharmaceutical Preparationsantimicrobial resistancebacterial pathogenesisgenomic epidemiologynosocomial outbreak
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.